An FDA Committee for FDA Advisory Committees
This article was originally published in RPM Report
Executive Summary
Drug sponsors craving consistency among the Food & Drug Administration's advisory committees take heart: changes are underway to make the process more predictable. FDA's Center for Drug Evaluation & Research is undertaking a one-year review of the advisory committee process to identify "best practices" that can be adopted across all the drug review divisions.